|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 06, 2019 09:46PM
|
|
Re: Bioasis announces a joint research collaboration with a leading pharmaceutical company.
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jan 07, 2019 09:07AM
|
|
Biotech Showcase Presentation is up
|
2
|
Resverlogix Corp.
|
Jan 07, 2019 08:08PM
|
|
Re: Biotech Showcase Presentation is up
|
3
|
Resverlogix Corp.
|
Jan 07, 2019 10:17PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 09:12AM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
3
|
Resverlogix Corp.
|
Jan 08, 2019 10:21AM
|
|
Re: Biotech Showcase
|
3
|
Zenith Epigenetics
|
Jan 08, 2019 11:15AM
|
|
Re: Bioasis To Present at Investor & Industry Conferences in January 2019
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 08, 2019 11:30AM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 05:49PM
|
|
Re: ZE Slides Up
|
5
|
Zenith Epigenetics
|
Jan 08, 2019 06:06PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
1
|
Resverlogix Corp.
|
Jan 09, 2019 09:35AM
|
|
Re: New price level when they announce 250 MACE Events,...?
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 12:47PM
|
|
Denali/Sirion deal to get AAVs across the BBB
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 09, 2019 01:34PM
|
|
Re: Denali/Sirion deal to get AAVs across the BBB
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 09, 2019 03:49PM
|
|
Re: How long would the last enrolled patient have to be in the trail before their stats would be included.
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 11:15PM
|
|
Re: Denali/Sirion deal to get AAVs across the BBB
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 10, 2019 10:18AM
|
|
The waiting game.....
|
5
|
Resverlogix Corp.
|
Jan 11, 2019 11:09AM
|
|
Pep Talk - Protein Science Week
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 14, 2019 11:31AM
|
|
Re: Esperion news, has this been discussed?
|
6
|
Resverlogix Corp.
|
Jan 15, 2019 11:00AM
|
|
Re: The waiting game.....
|
5
|
Resverlogix Corp.
|
Jan 15, 2019 11:18AM
|
